Updated Question and Answer Document Regarding Nitrosamines Impurities for Market Authorization Holders of Human Pharmaceutical Products

Posted Date: 23-June-2020

FDA Issues FY2023 Report on the State of Pharmaceutical Quality

Posted By:  Linitha Ganesh

Please login to view this content.